NI-0801

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNI-0801
Drug Alias NameEB-06Alpha-IP-10NI-0801α-IP-10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionC-X-C motif chemokine ligand 10 antagonists
TargetsC-X-C motif chemokine ligand 10
Therapy Area/IndicationsDermatitis, Allergic ContactLiver Cirrhosis, Biliary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovimmune Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEdesa Biotech IncLight Chain Bioscience Ltd
Active IndicationsN/A
Inactive IndicationsDermatitis, Allergic ContactLiver Cirrhosis, Biliary

Other Information

ATC CodeN/A
Related LinksN/A